Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MexAB-OprM multidrug efflux pump complex is a tripartite system in Pseudomonas aeruginosa, consisting of the inner membrane resistance-nodulation-division (RND) transporter MexB, the periplasmic membrane fusion protein MexA, and the outer membrane channel OprM. It spans the inner and outer membranes, using proton motive force to actively export a broad range of substrates from the cytoplasm and periplasm to the extracellular space, including structurally diverse antibiotics (e.g., β-lactams, fluoroquinolones, macrolides), detergents, dyes, organic solvents, quorum sensing molecules, and possibly virulence factors. MexB forms a trimeric pump that recognizes and captures substrates via vestibules and a central cavity, MexA oligomerizes to bridge MexB and OprM, and OprM provides a β-barrel channel open to the exterior. This pump is constitutively expressed at basal levels but upregulated via regulators like CpxR (binding the distal promoter) and mutations in repressors (e.g., MexR, NalD), contributing to intrinsic and acquired multidrug resistance in clinical isolates. Overexpression, particularly in nalB-type strains, reduces intracellular antibiotic accumulation, enabling resistance to multiple drugs and complicating treatment of P. aeruginosa infections such as pneumonia, sepsis, urinary tract infections, and chronic cystic fibrosis cases. Structural studies (e.g., cryo-EM) reveal its assembly and peristaltic mechanism for substrate translocation, informing efflux pump inhibitor development to restore antibiotic efficacy.
Efflux pump inhibition (targeting assembly or function to block drug export and restore antibiotic susceptibility)
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MexAB-OprM multidrug efflux pump complex (MexAB-OprM).